The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices
12-week certificate course commences on March 10th 2022
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The deepCDR engine combines deep sequencing and deep learning methods with a proprietary mammalian display process to select from a wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
Subscribe To Our Newsletter & Stay Updated
